2005
DOI: 10.1111/j.1525-1438.2005.00186.x
|View full text |Cite
|
Sign up to set email alerts
|

Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report

Abstract: Villoglandular papillary adenocarcinoma (VGPA) of the uterine cervix is a rare neoplasm, and its treatment has rarely been reported. We report a patient with VGPA stage IIA responding to neoadjuvant chemotherapy with docetaxel (60 mg/m2 as an intravenous infusion) and cisplatin (70 mg/m2 as an intra-arterial infusion). At 3 weeks after completing one course of this regimen, the tumor size was reduced from 5.3 x 4.0 cm to 2.0 x 2.0 cm (81.1% reduction), revealed by computed tomography. Accordingly, the patient … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2007
2007
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 15 publications
0
5
0
Order By: Relevance
“…The characteristic microscopic feature of VGA is the villoglandular architecture, with long and thin papillae with fibrovascular cores [ 11 ]. These papillae are lined with stratified columnar epithelium with mild-to-moderate nuclear atypia [ 2 ]. Immunohistochemical staining may be helpful in the pathological diagnosis of VGA.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The characteristic microscopic feature of VGA is the villoglandular architecture, with long and thin papillae with fibrovascular cores [ 11 ]. These papillae are lined with stratified columnar epithelium with mild-to-moderate nuclear atypia [ 2 ]. Immunohistochemical staining may be helpful in the pathological diagnosis of VGA.…”
Section: Discussionmentioning
confidence: 99%
“…Cervical adenocarcinoma is the second most common type of cervical cancer worldwide, accounting for approximately 10%–20% of all invasive cervical cancers [ 1 ], and has shown an increase in incidence in recent years. Villoglandular adenocarcinomas (VGAs), which account for approximately 5% of all cervical adenocarcinomas [ 2 ], are a rare subtype of cervical adenocarcinomas, first reported by Young and Scully in 1989 [ 1 ]. Recently, the International Endocervical Adenocarcinoma Criteria and Classification system categorized cervical adenocarcinomas into human papillomavirus (HPV)-associated adenocarcinomas and non-HPV-associated adenocarcinomas [ 3 ]; VGA is an HPV-associated adenocarcinoma.…”
Section: Introductionmentioning
confidence: 99%
“…2 The cytological features of VGPA on cervical smears are as follows: absence of neoplastic background; numerous abnormally stratified, papillary aggregations containing a large number of cells; a high N: C and small roundish nuclei; nuclear chromatin forming fine granules and some irregular, coarse granules; indistinct and occasionally small nucleoli. 3…”
Section: Pathological Discussionmentioning
confidence: 99%
“…1). The villoglandular structures are composed of stratified glandular cells, with mild to moderate nuclear atypia, and mitotic figures, with little or no budding from the villoglandular structures (9). A study by Macdonald et al (10) advised following the more recent changes in the definition of a villoglandular tumor rather than continuing to conform to a limited and conservative definition stating the presence of only villoglandular components, with no standard adenomatous or squamous features and no high-grade nuclear abnormalities.…”
Section: Discussionmentioning
confidence: 99%